Replies to post #28990 on Amarin Corp Plc (AMRN)

[alternatepatel]

"..Studies 'with Trilipix' enough to deny Vascepa indication, but not enough to withdraw Trilipix indication.."

Exactly. That's what annoys me a lot. I wonder (and fear) if FDA would withdraw mixed dyslipidemia indication from Trilipix label rather than granting it for Vascepa. An outcome of which none of us have thought of...